Is Australia falling behind on tobacco policy?

Sources: Office for National Statistics (UK). Smoking habits in the UK and its constituent countries, 2016. Australian Institute of Health and Welfare, National Drug Strategy Household Survey, 2016.

Updates: New Zealand moves / Media interviews

Update: two new submissions (available at Committee submissions page #336)

Clive Bates, Colin Mendelsohn. Do vapour products reduce or […]

English tobacco control plan embraces tobacco harm reduction - world first

Positive…

The Department of Health (UK/England) today released its tobacco control plan for England: Towards a smoke-free generation: tobacco control plan for England (PDF)

The embrace of vaping and other low-risk alternatives to smoking runs through the text. This is probably the first significant government policy paper anywhere that recognises and pursues the opportunities […]

American experts call for risk-based reform of FDA regulation of tobacco and nicotine

Note to FDA – this means you!

There have been two very encouraging initiatives in the United States in the last month, both captured in the form of letters to recently-appointed FDA Commissioner Scott Gottlieb.

Some of the most experienced US tobacco control experts are showing support for tobacco harm reduction and calling for […]

Hold the Mayo

Get a grip…

Once again the Mayo Clinic indulges in unethical and misleading risk communications in the form of a new article on e-cigarettes, promoting fear and confusion and dissuading smokers from trying them.

Mayo clinic: Electronic cigarettes: Not a safe way to light up

Update: Mayo Clinic subsequently (probably in June 2016) […]

Vaping and tobacco harm reduction in Ireland - consultation response in five quotes

Vaping in Ireland: already making a difference

On 5th January, Ireland’s Health Information and Quality Authority published a draft Health Technology Assessment on smoking cessation interventions with a press release. The assessment was positive about e-cigarettes.

Dr Máirín Ryan said: “This HTA found a high level of uncertainty surrounding both the clinical and cost-effectiveness […]